| Year |
Citation |
Score |
| 2021 |
Vellakkaran M, Kim T, Hong S. Visible-Light-Induced C4-Selective Functionalization of Pyridinium Salts with Cyclopropanols. Angewandte Chemie (International Ed. in English). PMID 34734455 DOI: 10.1002/anie.202113658 |
0.689 |
|
| 2020 |
Mathi GR, Kweon B, Moon Y, Jeong Y, Hong S. Regioselective C-H Functionalization of Heteroarene N-Oxides Enabled by a Traceless Nucleophile. Angewandte Chemie (International Ed. in English). PMID 32888227 DOI: 10.1002/Anie.202010597 |
0.326 |
|
| 2020 |
Choi H, Kim M, Jang J, Hong S. Visible-Light-Induced Cysteine-Specific Bioconjugation: Biocompatible Thiol-Ene Click Chemistry. Angewandte Chemie (International Ed. in English). PMID 32864829 DOI: 10.1002/Anie.202010217 |
0.308 |
|
| 2020 |
Lee K, Lee S, Kim N, Kim S, Hong S. Visible-Light-Enabled Trifluoromethylative Pyridylation of Alkenes from Pyridines and Triflic Anhydride. Angewandte Chemie (International Ed. in English). PMID 32368820 DOI: 10.1002/Anie.202004439 |
0.362 |
|
| 2020 |
Kim OH, Lee JH, Mah S, Park SY, Hong S, Hong SS. HS‑146, a novel phosphoinositide 3‑kinase α inhibitor, induces the apoptosis and inhibits the metastatic ability of human breast cancer cells. International Journal of Oncology. PMID 32236634 DOI: 10.3892/Ijo.2020.5018 |
0.351 |
|
| 2019 |
Jung HY, Chang S, Hong S. Strategic Approach to the Metamorphosis of γ-Lactones to NH γ-Lactams via Reductive Cleavage and C-H Amidation. Organic Letters. PMID 31418279 DOI: 10.1021/Acs.Orglett.9B02673 |
0.34 |
|
| 2019 |
Kim IS, Lee H, Kang D, Han SH, Chun R, Pandey AK, Mishra NK, Hong S. Allylic Acetals as Acrolein Oxonium Precursors in Tandem C-H Allylation and [3+2] Dipolar Cycloaddition. Angewandte Chemie (International Ed. in English). PMID 31069937 DOI: 10.1002/Anie.201903983 |
0.388 |
|
| 2018 |
Park JH, Jung KH, Kim SJ, Yoon YC, Yan HH, Fang Z, Lee JE, Lim JH, Mah S, Hong S, Kim YS, Hong SS. HS-173 as a novel inducer of RIP3-dependent necroptosis in lung cancer. Cancer Letters. PMID 30583075 DOI: 10.1016/J.Canlet.2018.12.006 |
0.324 |
|
| 2018 |
Im H, Kang D, Choi S, Shin S, Hong S. Visible-Light-Induced C-O Bond Formation for the Construction of Five- and Six-Membered Cyclic Ethers and Lactones. Organic Letters. PMID 30427687 DOI: 10.1021/Acs.Orglett.8B03166 |
0.35 |
|
| 2018 |
Kim I, Park B, Kang G, Kim J, Jung H, Lee H, Baik MH, Hong S. Metal-Free, Visible-Light-Induced Remote C(sp3)-H Pyridylation via Radical Translocation of N-Alkoxypyridinium Salts. Angewandte Chemie (International Ed. in English). PMID 30277296 DOI: 10.1002/Anie.201809879 |
0.342 |
|
| 2018 |
Park HH, Park SY, Mah S, Park JH, Hong SS, Hong S, Kim YS. HS-1371, a novel kinase inhibitor of RIP3-mediated necroptosis. Experimental & Molecular Medicine. 50: 125. PMID 30237400 DOI: 10.1038/S12276-018-0152-8 |
0.373 |
|
| 2018 |
Pandey AK, Kang D, Han SH, Lee H, Mishra NK, Kim HS, Jung YH, Hong S, Kim IS. Reactivity of Morita-Baylis-Hillman Adducts in C-H Functionalization of (Hetero)aryl Nitrones: Access to Bridged Cycles and Carbazoles. Organic Letters. PMID 30047738 DOI: 10.1021/Acs.Orglett.8B01910 |
0.372 |
|
| 2018 |
Kim Y, Kim ST, Kang D, Sohn TI, Jang E, Baik MH, Hong S. Stereoselective construction of sterically hindered oxaspirocycles chiral bidentate directing group-mediated C(sp)-O bond formation. Chemical Science. 9: 1473-1480. PMID 29629170 DOI: 10.1039/C7Sc04691J |
0.37 |
|
| 2018 |
Han SH, Pandey AK, Lee H, Kim S, Kang D, Jung YH, Kim HS, Hong S, Kim IS. One-pot synthesis of 2-naphthols from nitrones and MBH adducts via decarboxylative N–O bond cleavage Organic Chemistry Frontiers. 5: 3210-3218. DOI: 10.1039/C8Qo00988K |
0.33 |
|
| 2017 |
Moon Y, Jang E, Choi S, Hong S. Visible-Light-Photocatalyzed Synthesis of Phenanthridinones and Quinolinones via Direct Oxidative C-H Amidation. Organic Letters. PMID 29239619 DOI: 10.1021/Acs.Orglett.7B03600 |
0.348 |
|
| 2017 |
Mah S, Park JH, Jung HY, Ahn K, Choi S, Tae HS, Jung KH, Rho JK, Lee JC, Hong SS, Hong S. Identification of 4-Phenoxyquinoline Based Inhibitors for L1196M Mutant of Anaplastic Lymphoma Kinase by Structure-Based Design. Journal of Medicinal Chemistry. PMID 29091425 DOI: 10.1021/Acs.Jmedchem.7B01039 |
0.381 |
|
| 2017 |
Park H, Jung HY, Mah S, Hong S. Discovery of EGFR(d746-750/T790M/C797S) Mutant-Selective Inhibitors via Structure-Based de Novo Design. Angewandte Chemie (International Ed. in English). PMID 28493467 DOI: 10.1002/Ange.201703389 |
0.355 |
|
| 2017 |
Pandey AK, Han SH, Mishra NK, Kang D, Lee SH, Chun R, Hong S, Park JS, Kim IS. Synthesis of 2-Benzazepines from Benzylamines and MBH Adducts Under Rhodium(III) Catalysis via C(sp2)–H Functionalization Acs Catalysis. 8: 742-746. DOI: 10.1021/Acscatal.7B03812 |
0.365 |
|
| 2017 |
Jung S, Kim J, Hong S. Visible Light-Promoted Synthesis of Spiroepoxy Chromanone Derivatives via a Tandem Oxidation/Radical Cyclization/Epoxidation Process Advanced Synthesis & Catalysis. 359: 3945-3949. DOI: 10.1002/Adsc.201701072 |
0.341 |
|
| 2016 |
Choi H, Min M, Peng Q, Kang D, Paton RS, Hong S. Unraveling innate substrate control in site-selective palladium-catalyzed C-H heterocycle functionalization. Chemical Science. 7: 3900-3909. PMID 30155034 DOI: 10.1039/C5Sc04590H |
0.361 |
|
| 2016 |
Kim J, Moon Y, Hong S. Identification of lead small molecule inhibitors of glycogen synthase kinase-3 beta using a fragment-linking strategy. Bioorganic & Medicinal Chemistry Letters. PMID 27815120 DOI: 10.1016/J.Bmcl.2016.10.060 |
0.365 |
|
| 2016 |
Rumman M, Jung KH, Fang Z, Yan HH, Son MK, Kim SJ, Kim J, Park JH, Lim JH, Hong S, Hong SS. HS-173, a novel PI3K inhibitor suppresses EMT and metastasis in pancreatic cancer. Oncotarget. PMID 27793006 DOI: 10.18632/Oncotarget.12871 |
0.32 |
|
| 2016 |
Park H, Shin Y, Kim J, Hong S. Application of Fragment-Based De Novo Design to the Discovery of Selective Picomolar Inhibitors of Glycogen Synthase Kinase-3 beta. Journal of Medicinal Chemistry. PMID 27676184 DOI: 10.1021/Acs.Jmedchem.6B00944 |
0.366 |
|
| 2016 |
Shin Y, Lim SM, Yan HH, Jung S, Fang Z, Jung KH, Hong SS, Hong S. Optimization and biological evaluation of aminopyrimidine-based IκB kinase β inhibitors with potent anti-inflammatory effects. European Journal of Medicinal Chemistry. 123: 544-556. PMID 27517803 DOI: 10.1016/J.Ejmech.2016.07.075 |
0.319 |
|
| 2016 |
Kim K, Vasu D, Im H, Hong S. Palladium(II)-Catalyzed Tandem Synthesis of Acenes Using Carboxylic Acids as Traceless Directing Groups. Angewandte Chemie (International Ed. in English). PMID 27244536 DOI: 10.1002/Anie.201603661 |
0.397 |
|
| 2016 |
Lim SM, Jeong Y, Hong S. Strategies to overcome acquired resistances conferred by mutations in the kinase domain of EGFR. Future Medicinal Chemistry. PMID 27195594 DOI: 10.4155/Fmc-2016-0019 |
0.306 |
|
| 2016 |
Shin S, Mah S, Hong S, Park H. Discovery of low micromolar dual inhibitors for wild type and L1196M mutant of anaplastic lymphoma kinase through the structure-based virtual screening. Journal of Chemical Information and Modeling. PMID 27014917 DOI: 10.1021/Acs.Jcim.6B00026 |
0.366 |
|
| 2016 |
Park H, Lee S, Hong S. Discovery of Dual Inhibitors for Wild Type and D816V Mutant of c-KIT Kinase through Virtual and Biochemical Screening of Natural Products. Journal of Natural Products. PMID 26807861 DOI: 10.1021/Acs.Jnatprod.5B00851 |
0.383 |
|
| 2016 |
Moon Y, Kwon S, Kang D, Im H, Hong S. Palladium-Catalyzed Divergent Arylation with Triazolopyridines Advanced Synthesis and Catalysis. DOI: 10.1002/Adsc.201600214 |
0.315 |
|
| 2015 |
Kim J, Sim M, Kim N, Hong S. Asymmetric C-H functionalization of cyclopropanes using an isoleucine-NHbidentate directing group. Chemical Science. 6: 3611-3616. PMID 29511524 DOI: 10.1039/C5Sc01137J |
0.358 |
|
| 2015 |
Lim SM, Jeong Y, Lee S, Im H, Tae HS, Kim BG, Park HD, Park J, Hong S. Identification of β-Lapachone Analogs as Novel MALT1 Inhibitors To Treat an Aggressive Subtype of Diffuse Large B-Cell Lymphoma. Journal of Medicinal Chemistry. PMID 26496175 DOI: 10.1021/Acs.Jmedchem.5B01415 |
0.377 |
|
| 2015 |
Jeong Y, Lim SM, Hong S. Discovery of wrightiadione as a novel template for the TrkA kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. PMID 26442778 DOI: 10.1016/J.Bmcl.2015.09.070 |
0.391 |
|
| 2015 |
Park H, Lee S, Hong S. Structure-based de novo design and synthesis of aminothiazole-based p38 MAP kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. PMID 26259807 DOI: 10.1016/J.Bmcl.2015.07.094 |
0.356 |
|
| 2015 |
Kim Y, Hong S. Rh(iii)-catalyzed 7-azaindole synthesis via C-H activation/annulative coupling of aminopyridines with alkynes. Chemical Communications (Cambridge, England). 51: 11202-5. PMID 26077013 DOI: 10.1039/C5Cc03497C |
0.378 |
|
| 2015 |
Kim K, Choe H, Jeong Y, Lee JH, Hong S. Ru(II)-Catalyzed Site-Selective Hydroxylation of Flavone and Chromone Derivatives: The Importance of the 5-Hydroxyl Motif for the Inhibition of Aurora Kinases. Organic Letters. 17: 2550-3. PMID 25946086 DOI: 10.1021/acs.orglett.5b01138 |
0.306 |
|
| 2015 |
Kang D, Hong S. Rh(III) and Ru(II)-catalyzed site-selective C-H alkynylation of quinolones. Organic Letters. 17: 1938-41. PMID 25822001 DOI: 10.1021/Acs.Orglett.5B00641 |
0.353 |
|
| 2015 |
Park H, Shin Y, Choe H, Hong S. Computational design and discovery of nanomolar inhibitors of IκB kinase β. Journal of the American Chemical Society. 137: 337-48. PMID 25513719 DOI: 10.1021/Ja510636T |
0.374 |
|
| 2015 |
Kim SJ, Jung KH, Yan HH, Son MK, Fang Z, Ryu YL, Lee H, Lim JH, Suh JK, Kim J, Lee S, Hong S, Hong SS. HS-543 induces apoptosis of Imatinib-resistant chronic myelogenous leukemia with T315I mutation. Oncotarget. 6: 1507-18. PMID 25483100 DOI: 10.18632/Oncotarget.2837 |
0.313 |
|
| 2015 |
Shin Y, Yoo C, Moon Y, Lee Y, Hong S. Efficient synthesis of frutinone A and its derivatives through palladium-catalyzed C - H activation/carbonylation. Chemistry, An Asian Journal. 10: 878-81. PMID 25252104 DOI: 10.1002/Asia.201402876 |
0.374 |
|
| 2014 |
Lee JH, Jung KH, Lee H, Son MK, Yun SM, Ahn SH, Lee KR, Lee S, Kim D, Hong S, Hong SS. HS-133, a novel fluorescent phosphatidylinositol 3-kinase inhibitor as a potential imaging and anticancer agent for targeted therapy. Oncotarget. 5: 10180-97. PMID 25338206 DOI: 10.18632/Oncotarget.2507 |
0.328 |
|
| 2014 |
Ryu YL, Jung KH, Son MK, Yan HH, Kim SJ, Shin S, Hong S, Hong SS. Anticancer activity of HS-527, a novel inhibitor targeting PI3-kinase in human pancreatic cancer cells. Cancer Letters. 353: 68-77. PMID 25016056 DOI: 10.1016/J.Canlet.2014.07.001 |
0.344 |
|
| 2014 |
Lee S, Lee H, Kim J, Lee S, Kim SJ, Choi BS, Hong SS, Hong S. Development and biological evaluation of potent and selective c-KIT(D816V) inhibitors. Journal of Medicinal Chemistry. 57: 6428-43. PMID 25004409 DOI: 10.1021/Jm500413G |
0.367 |
|
| 2014 |
Park H, Lee S, Lee S, Hong S. Structure-based de novo design and identification of D816V mutant-selective c-KIT inhibitors. Organic & Biomolecular Chemistry. 12: 4644-55. PMID 24853767 DOI: 10.1039/C4Ob00053F |
0.387 |
|
| 2014 |
Jung KH, Yan HH, Fang Z, Son MK, Lee H, Hong S, Hong SS. HS-104, a PI3K inhibitor, enhances the anticancer efficacy of gemcitabine in pancreatic cancer. International Journal of Oncology. 45: 311-21. PMID 24819705 DOI: 10.3892/Ijo.2014.2435 |
0.334 |
|
| 2014 |
Park H, Choe H, Hong S. Virtual screening and biochemical evaluation to identify new inhibitors of mammalian target of rapamycin (mTOR). Bioorganic & Medicinal Chemistry Letters. 24: 835-8. PMID 24393580 DOI: 10.1016/J.Bmcl.2013.12.081 |
0.362 |
|
| 2013 |
Son MK, Ryu YL, Jung KH, Lee H, Lee HS, Yan HH, Park HJ, Ryu JK, Suh JK, Hong S, Hong SS. HS-173, a novel PI3K inhibitor, attenuates the activation of hepatic stellate cells in liver fibrosis. Scientific Reports. 3: 3470. PMID 24326778 DOI: 10.1038/Srep03470 |
0.302 |
|
| 2013 |
Choe H, Kim J, Hong S. Structure-based design of flavone-based inhibitors of wild-type and T315I mutant of ABL. Bioorganic & Medicinal Chemistry Letters. 23: 4324-7. PMID 23790540 DOI: 10.1016/J.Bmcl.2013.05.095 |
0.334 |
|
| 2013 |
Lee H, Kim SJ, Jung KH, Son MK, Yan HH, Hong S, Hong SS. A novel imidazopyridine PI3K inhibitor with anticancer activity in non-small cell lung cancer cells. Oncology Reports. 30: 863-9. PMID 23708425 DOI: 10.3892/Or.2013.2499 |
0.33 |
|
| 2013 |
Park H, Hong S, Kim J, Hong S. Discovery of picomolar ABL kinase inhibitors equipotent for wild type and T315I mutant via structure-based de novo design. Journal of the American Chemical Society. 135: 8227-37. PMID 23679864 DOI: 10.1021/Ja311756U |
0.349 |
|
| 2013 |
Yun SM, Lee JH, Jung KH, Lee H, Lee S, Hong S, Hong SS. Induction of apoptosis and suppression of angiogenesis of hepatocellular carcinoma by HS-159, a novel phosphatidylinositol 3-kinase inhibitor. International Journal of Oncology. 43: 201-9. PMID 23604199 DOI: 10.3892/Ijo.2013.1912 |
0.357 |
|
| 2013 |
Hong S, Kim J, Yun SM, Lee H, Park Y, Hong SS, Hong S. Discovery of new benzothiazole-based inhibitors of breakpoint cluster region-Abelson kinase including the T315I mutant. Journal of Medicinal Chemistry. 56: 3531-45. PMID 23600806 DOI: 10.1021/Jm301891T |
0.359 |
|
| 2013 |
Jung KH, Ryu YL, Lee HS, Lee H, Son MK, Yan HH, Hong SW, Ryu JK, Hong S, Suh JK, Hong SS. A novel PI3K inhibitor alleviates fibrotic responses in fibroblasts derived from Peyronie's plaques. International Journal of Oncology. 42: 2001-8. PMID 23588860 DOI: 10.3892/Ijo.2013.1905 |
0.321 |
|
| 2013 |
Seo JH, Jung KH, Son MK, Yan HH, Ryu YL, Kim J, Lee JK, Hong S, Hong SS. Anti-cancer effect of HS-345, a new tropomyosin-related kinase A inhibitor, on human pancreatic cancer. Cancer Letters. 338: 271-81. PMID 23587795 DOI: 10.1016/J.Canlet.2013.04.002 |
0.331 |
|
| 2013 |
Yun SM, Jung KH, Lee H, Son MK, Seo JH, Yan HH, Park BH, Hong S, Hong SS. Synergistic anticancer activity of HS-173, a novel PI3K inhibitor in combination with Sorafenib against pancreatic cancer cells. Cancer Letters. 331: 250-61. PMID 23340175 DOI: 10.1016/J.Canlet.2013.01.007 |
0.361 |
|
| 2013 |
Lee JH, Lee H, Yun SM, Jung KH, Jeong Y, Yan HH, Hong S, Hong SS. IPD-196, a novel phosphatidylinositol 3-kinase inhibitor with potent anticancer activity against hepatocellular carcinoma. Cancer Letters. 329: 99-108. PMID 23142281 DOI: 10.1016/J.Canlet.2012.10.028 |
0.346 |
|
| 2013 |
Li GY, Jung KH, Lee H, Son MK, Seo J, Hong SW, Jeong Y, Hong S, Hong SS. A novel imidazopyridine derivative, HS-106, induces apoptosis of breast cancer cells and represses angiogenesis by targeting the PI3K/mTOR pathway. Cancer Letters. 329: 59-67. PMID 23085493 DOI: 10.1016/J.Canlet.2012.10.013 |
0.346 |
|
| 2013 |
Lee H, Jung KH, Jeong Y, Hong S, Hong SS. HS-173, a novel phosphatidylinositol 3-kinase (PI3K) inhibitor, has anti-tumor activity through promoting apoptosis and inhibiting angiogenesis. Cancer Letters. 328: 152-9. PMID 22929971 DOI: 10.1016/J.Canlet.2012.08.020 |
0.354 |
|
| 2013 |
Jung KH, Zheng HM, Jeong Y, Choi MJ, Lee H, Hong SW, Lee HS, Son MK, Lee S, Hong S, Hong SS. Suppression of tumor proliferation and angiogenesis of hepatocellular carcinoma by HS-104, a novel phosphoinositide 3-kinase inhibitor. Cancer Letters. 328: 176-87. PMID 22902995 DOI: 10.1016/J.Canlet.2012.08.005 |
0.329 |
|
| 2012 |
Moon Y, Kwon D, Hong S. Palladium-catalyzed dehydrogenation/oxidative cross-coupling sequence of β-heteroatom-substituted ketones. Angewandte Chemie (International Ed. in English). 51: 11333-6. PMID 23038616 DOI: 10.1002/Anie.201206610 |
0.324 |
|
| 2012 |
Min M, Hong S. Regioselective palladium-catalyzed direct cross-coupling of coumarins with simple arenes. Chemical Communications (Cambridge, England). 48: 9613-5. PMID 22908116 DOI: 10.1039/C2Cc34551J |
0.327 |
|
| 2012 |
Park H, Hong S, Hong S. Identification of common inhibitors of wild-type and T315I mutant of BCR-ABL through the parallel structure-based virtual screening. Journal of Computer-Aided Molecular Design. 26: 983-92. PMID 22886487 DOI: 10.1007/S10822-012-9593-7 |
0.355 |
|
| 2012 |
Kim D, Ham K, Hong S. Synthetic approach to flavanones and flavones via ligand-free palladium(II)-catalyzed conjugate addition of arylboronic acids to chromones. Organic & Biomolecular Chemistry. 10: 7305-12. PMID 22850763 DOI: 10.1039/C2Ob26061A |
0.33 |
|
| 2012 |
Park H, Lee S, Hong S. Discovery of MEK/PI3K dual inhibitor via structure-based virtual screening. Bioorganic & Medicinal Chemistry Letters. 22: 4946-50. PMID 22771009 DOI: 10.1016/J.Bmcl.2012.06.041 |
0.368 |
|
| 2012 |
Moon Y, Hong S. A facile route to isoflavone quinones via the direct cross-coupling of chromones and quinones. Chemical Communications (Cambridge, England). 48: 7191-3. PMID 22688381 DOI: 10.1039/C2Cc33204C |
0.301 |
|
| 2012 |
Hong S, Kim J, Seo JH, Jung KH, Hong SS, Hong S. Design, synthesis, and evaluation of 3,5-disubstituted 7-azaindoles as Trk inhibitors with anticancer and antiangiogenic activities. Journal of Medicinal Chemistry. 55: 5337-49. PMID 22575050 DOI: 10.1021/Jm3002982 |
0.401 |
|
| 2012 |
Park H, Jeong Y, Hong S. Structure-based de novo design and biochemical evaluation of novel BRAF kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 22: 1027-30. PMID 22196123 DOI: 10.1016/J.Bmcl.2011.11.124 |
0.375 |
|
| 2012 |
Jung KH, Choi MJ, Hong S, Lee H, Hong SW, Zheng HM, Lee HS, Hong S, Hong SS. HS-116, a novel phosphatidylinositol 3-kinase inhibitor induces apoptosis and suppresses angiogenesis of hepatocellular carcinoma through inhibition of the PI3K/AKT/mTOR pathway. Cancer Letters. 316: 187-95. PMID 22182943 DOI: 10.1016/J.Canlet.2011.10.037 |
0.326 |
|
| 2012 |
Park H, Hong S, Hong S. Nocodazole is a high-affinity ligand for the cancer-related kinases ABL, c-KIT, BRAF, and MEK. Chemmedchem. 7: 53-6. PMID 22002881 DOI: 10.1002/Cmdc.201100410 |
0.32 |
|
| 2011 |
Kim J, Hong S, Hong S. Discovery of new aminopyrimidine-based phosphoinositide 3-kinase beta (PI3Kβ) inhibitors with selectivity over PI3Kα. Bioorganic & Medicinal Chemistry Letters. 21: 6977-81. PMID 22030027 DOI: 10.1016/J.Bmcl.2011.09.118 |
0.389 |
|
| 2011 |
Park H, Chi O, Kim J, Hong S. Identification of novel inhibitors of tropomyosin-related kinase A through the structure-based virtual screening with homology-modeled protein structure. Journal of Chemical Information and Modeling. 51: 2986-93. PMID 22017333 DOI: 10.1021/Ci200378S |
0.364 |
|
| 2011 |
Park H, Choi H, Hong S, Hong S. Identification of novel BRAF kinase inhibitors with structure-based virtual screening. Bioorganic & Medicinal Chemistry Letters. 21: 5753-6. PMID 21873050 DOI: 10.1016/J.Bmcl.2011.08.010 |
0.378 |
|
| 2011 |
Kim D, Hong S. Palladium(II)-catalyzed direct intermolecular alkenylation of chromones. Organic Letters. 13: 4466-9. PMID 21797199 DOI: 10.1021/Ol2018278 |
0.351 |
|
| 2011 |
Kim D, Lee H, Jun H, Hong SS, Hong S. Fluorescent phosphoinositide 3-kinase inhibitors suitable for monitoring of intracellular distribution. Bioorganic & Medicinal Chemistry. 19: 2508-16. PMID 21459582 DOI: 10.1016/J.Bmc.2011.03.025 |
0.301 |
|
| 2011 |
Kim O, Jeong Y, Lee H, Hong SS, Hong S. Design and synthesis of imidazopyridine analogues as inhibitors of phosphoinositide 3-kinase signaling and angiogenesis. Journal of Medicinal Chemistry. 54: 2455-66. PMID 21388141 DOI: 10.1021/Jm101582Z |
0.417 |
|
| 2011 |
Park H, Choi H, Hong S, Kim D, Oh DS, Hong S. Structure-based virtual screening approach to the discovery of phosphoinositide 3-kinase alpha inhibitors. Bioorganic & Medicinal Chemistry Letters. 21: 2021-4. PMID 21354792 DOI: 10.1016/J.Bmcl.2011.02.015 |
0.363 |
|
| 2011 |
Park H, Choi H, Hong S, Kim D, Oh DS. Corrigendum to Structure-based virtual screening approach to the discovery of phosphoinositide 3-kinase alpha inhibitors (Bioorganic & Medicinal Chemistry Letters (2011) 21, (2021-2024) DOI: 10.1016/j.bmcl.2011.02.015) Bioorganic and Medicinal Chemistry Letters. 21: 3839. DOI: 10.1016/J.Bmcl.2011.04.109 |
0.306 |
|
| 2010 |
Kim D, Jun H, Lee H, Hong SS, Hong S. Development of new fluorescent xanthines as kinase inhibitors. Organic Letters. 12: 1212-5. PMID 20184370 DOI: 10.1021/Ol100011N |
0.393 |
|
| 2008 |
Liu P, Hong S, Weinreb SM. Total synthesis of the Securinega alkaloid (-)-secu'amamine A. Journal of the American Chemical Society. 130: 7562-3. PMID 18491903 DOI: 10.1021/Ja802700Z |
0.553 |
|
| 2008 |
Liu P, Hong S, Weinreb SM. ChemInform Abstract: Total Synthesis of the Securinega Alkaloid (-)-Secu′amamine A. Cheminform. 39. DOI: 10.1002/chin.200842197 |
0.484 |
|
| 2006 |
Liu D, Hong S, Corey EJ. Enantioselective synthesis of bridged- or fused-ring bicyclic ketones by a catalytic asymmetric Michael addition pathway. Journal of the American Chemical Society. 128: 8160-1. PMID 16787080 DOI: 10.1021/Ja063332Y |
0.459 |
|
| 2006 |
Yeung YY, Hong S, Corey EJ. A short enantioselective pathway for the synthesis of the anti-influenza neuramidase inhibitor oseltamivir from 1,3-butadiene and acrylic acid. Journal of the American Chemical Society. 128: 6310-1. PMID 16683783 DOI: 10.1021/Ja0616433 |
0.63 |
|
| 2006 |
Hong S, Yang J, Weinreb SM. Construction of an advanced tetracyclic intermediate for total synthesis of the marine alkaloid sarain A. The Journal of Organic Chemistry. 71: 2078-89. PMID 16496996 DOI: 10.1021/Jo052504R |
0.575 |
|
| 2006 |
Hong S, Corey EJ. Enantioselective syntheses of georgyone, arborone, and structural relatives. Relevance to the molecular-level understanding of olfaction. Journal of the American Chemical Society. 128: 1346-52. PMID 16433554 DOI: 10.1021/Ja057483X |
0.383 |
|
| Show low-probability matches. |